CCAAT-Enhancer-Binding Protein-alpha
"CCAAT-Enhancer-Binding Protein-alpha" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CCAAT-enhancer-binding protein found in LIVER; ADIPOSE TISSUE; INTESTINES; LUNG; ADRENAL GLANDS; PLACENTA; OVARY and peripheral blood mononuclear cells (LEUKOCYTES, MONONUCLEAR). Experiments with knock-out mice have demonstrated that CCAAT-enhancer binding protein-alpha is essential for the functioning and differentiation of HEPATOCYTES and ADIPOCYTES.
Descriptor ID |
D022763
|
MeSH Number(s) |
D12.776.260.108.124.500 D12.776.660.167.500 D12.776.930.127.124.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "CCAAT-Enhancer-Binding Protein-alpha".
Below are MeSH descriptors whose meaning is more specific than "CCAAT-Enhancer-Binding Protein-alpha".
This graph shows the total number of publications written about "CCAAT-Enhancer-Binding Protein-alpha" by people in this website by year, and whether "CCAAT-Enhancer-Binding Protein-alpha" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "CCAAT-Enhancer-Binding Protein-alpha" by people in Profiles.
-
Identification of C/EBPa as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes. PLoS Pathog. 2017 Jun; 13(6):e1006406.
-
CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features. Haematologica. 2017 03; 102(3):529-540.
-
The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. J Biochem. 2008 Jul; 144(1):51-62.